Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T56625 | ||||
Target Name | Tripeptidyl-peptidase II (TPP2) | ||||
Type of Target |
Discontinued |
||||
Drug Potency against Target | UCL-2000; butabindide | Drug Info | IC50 = 7 nM | [2] | |
(2S)-aminobutyryl-(R)-pipecolinic acid amide | Drug Info | Ki = 12000 nM | [1] | ||
(2S)-aminobutyryl-L-prolinamide | Drug Info | Ki = 570 nM | [1] | ||
(2S)-aminobutyryl-L-proline (R)-sec-butylamide | Drug Info | Ki = 4500 nM | [1] | ||
(2S)-aminobutyryl-L-proline isobutylamide | Drug Info | Ki = 320 nM | [1] | ||
(2S)-aminobutyryl-L-proline n-butylamide | Drug Info | Ki = 80 nM | [1] | ||
(2S)-aminobutyryl-L-proline n-pentylamide | Drug Info | Ki = 270 nM | [1] | ||
(2S)-aminobutyryl-L-proline n-propylamide | Drug Info | Ki = 80 nM | [1] | ||
(2S)-aminobutyryl-L-proline-(2S)-methylbutylamide | Drug Info | Ki = 500 nM | [1] | ||
Alpha-methylalanyl-L-proline butylamide | Drug Info | Ki = 5000 nM | [1] | ||
L-isoleucyl-L-prolinamide | Drug Info | Ki = 4300 nM | [1] | ||
L-leucyl-L-prolinamide | Drug Info | Ki = 2100 nM | [1] | ||
L-norleucyl-L-prolinamide | Drug Info | Ki = 2000 nM | [1] | ||
L-norvalyl-L-prolinamide | Drug Info | Ki = 1600 nM | [1] | ||
L-valyl-L-prolinamide | Drug Info | Ki = 6000 nM | [1] | ||
L-valyl-L-proline benzylamide | Drug Info | Ki = 3300 nM | [1] | ||
L-valyl-L-proline hexylamide | Drug Info | Ki = 900 nM | [1] | ||
References | |||||
REF 1 | Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach ... J Med Chem. 2005 Nov 17;48(23):7333-42. | ||||
REF 2 | Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indoles. J Med Chem. 2002 Nov 21;45(24):5303-10. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.